Tinea
Fibroids
Nails
SCFE
HFpEF
100

Name the different types of superficial tinea infections (at least 3/5)

capitis, corporis, cruris, pedis, unguium (onychomycosis)

100

Diagnostic tool of choice for uterine fibroids

TV, transabdominal US
100
How can a systemic condition affecting nails vs a process like infection/trauma/tumor be differentiated?

Multiple nails vs single nail affected

100

Most common presentation for SCFE

Knee/distal thigh pain in 23% of pts

Limping can occur as well

100

Name 2 sx, 3 signs of HFpEF

Signs: elevated JVP, HJR, lateral displacement of apical impulse, s3; less specific: ascites, cachexia, murmur, hepatomegaly, decreased extremity perfusion, edema, pleural effusion, weight gain, weight loss

Symptoms: ankle edema, dyspnea, fatigue, orthopnea, pnd, reduced exercise tolerance
200

True or False: combo products such as lotrisone are a good option in instances of diagnostic uncertainty

bonus: name the components of lotrisone

No: they can result in skin atrophy, systemic adverse effects

Clotrimazole, betamethasone

200

Initial therapy for heavy or AUB? 

Oral contraceptive, levonorgestrel IUD

NSAIDs/tranexamic acid can be used

200

Important elements of Hx when evaluating nail abnormalities? name 3

Diet, duration of sx, fhx, hobbies: infx/toxic exposure, medical hx, medications, nail care habits, affected nails, occupation: infx/toxic/traumatic exposure

200

Diagnostic evaluation should include what type of radiography

Hip: AP, Frog-leg lateral views

200

The cutoffs for

- normal EF

- HFpEF

- HFrEF

- HFmrEF

- normal EF: >50

- HFpEF: same

- HFrEF: <40

-HFmrEF: 40-50

300
Treatment of onychomycosis

Oral recommended: terbinafine 250 mg daily for 6-12 weeks

Can use topical efinaconazole, topical ciclopirox, topical tavabarole for mild/moderate cases

Jublia is wildly expensive

300

Name four factors that increase or decrease risk for fibroids

Decrease: increased parity, late menarche, depo use, COC use. 

Possible decrease: high fruit/veggie intake

Increase: age > 40, black, early menarche <10, increased time since last birth, FHx, nulliparity, obesity, premenopausal

May increase: food additives, htn, vitamin D deficiency

300

Name and define two shape abnormalities of nails

Clubbing: nails enlarge and curve: usually due to cardiopulmonary, hepatic, or GI d/o

Koilonychia: spoon nail: concave, central depression/lateral elevation. Vascular changes, enzyme abnormalities. Can be familial. Can be normal in absence of other findings in children. IDA, toxins, trauma. 

300

Findings on imaging for SCFE? Name 1 of 3 key findings

Klein's line (follows femoral neck does not intersect with femoral head): Trethowan sign

Steel sign: blurring of femoral metaphysis due to overlap of metaphysis/slipped epiphysis

Widened physis: widening of clear growth plate

300

The drug that reduces mortality for HFpEF

SGLT-2 inhibitors

mortality benefit in ef >40

  • can improve sx, qol, reduce hosp (nnt 28)
  • lesser mortality benefit than in hfref
  • can use with GFR > 25
400

Findings that best rule in dermatomycosis name all 3 for full credit

maceration, concentric rings, central clearing

400

Risk factors that would raise suspicion for cancer: name 2

Radiation exposure, li fraumeni or other genetic syndrome, post menopausal, previous tamoxifen use

400

Name 3 nail changes that can occur with psoriasis

Nail pitting, leukonychia, brittle nails, Beau lines, trachyonychia, oil drops, salmon-colored patches, and splinter hemorrhages

>1/2 pts with psoriasis will have nail involvement. tx with steroid injection to nail fold, topical steroids, vit D analogues, systemic therapy can be used if there are other sx

400

What type of SCFE is associated with osteonecrosis and when should surgery be performed?

Unstable. w/in 24h or after 72h

400

Other medicines that can help with HFpEF (3)

  • ARB, preferred over acei
  • MRA reduces hosp
  • Entresto: no hosp improvement, improved with EF b/t 45-57
500

Tinea corporis, cruris, pedis treatment principles

Usually topicals such as ketoconazole, terbinafine

Oral if extensive disease, lack of response to topical treatment, immunocompromise, hair follicle involvement
500

PALM-COEIN name all elements

DDx for AUB

Structural causes: polyps, adenomyosis, leiomyoma, malignancy/hyperplasia

Nonstructural causes: coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified


500

Two part question: Characteristics of patient that should prompt addnl workup; list the workup

Age: <10 or >16

Height or weight <10th  percentile

Endocrine w/u: TSH, PTH, CMP, Vit D, GH

500

Non pharmacologic measures that can help with HFpEF

aerobic activity, cardiac rehab, low Na diet